CO5700713A2 - Una composicion farmaceutica para la prevencion y tratamiento de adiccion a nicotina en un mamifero - Google Patents
Una composicion farmaceutica para la prevencion y tratamiento de adiccion a nicotina en un mamiferoInfo
- Publication number
- CO5700713A2 CO5700713A2 CO05113614A CO05113614A CO5700713A2 CO 5700713 A2 CO5700713 A2 CO 5700713A2 CO 05113614 A CO05113614 A CO 05113614A CO 05113614 A CO05113614 A CO 05113614A CO 5700713 A2 CO5700713 A2 CO 5700713A2
- Authority
- CO
- Colombia
- Prior art keywords
- addiction
- dependence
- tobacco
- treatment
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Addiction (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
1.- Una composición farmacéutica para tratar dependencia o adicción a nicotina, dependencia o adicción a tabaco, para reducir los síntomas de abstinencia de nicotina o para ayudar en el cese o disminución de uso de tabaco o abuso de sustancias o dependencias conductuales que comprende:(a) un agonista parcial de receptores nicotínicos o una sal farmacéuticamente aceptable del mismo;(b) un antagonista del receptor CB-1 o una sal farmacéuticamente aceptable del mismo; y (c) un vehículo farmacéuticamente aceptable;en la que los agentes activos "a" y "b" anteriores están presentes en cantidades que hacen la composición eficaz en el tratamiento de dependencia o adicción a nicotina, dependencia o adicción a tabaco, en la reducción de los síntomas de abstinencia de nicotina o en la ayuda en el cese o disminución de uso de tabaco o abuso de sustancias o dependencias conductuales.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US46942903P | 2003-05-09 | 2003-05-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO5700713A2 true CO5700713A2 (es) | 2006-11-30 |
Family
ID=33435233
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO05113614A CO5700713A2 (es) | 2003-05-09 | 2005-11-09 | Una composicion farmaceutica para la prevencion y tratamiento de adiccion a nicotina en un mamifero |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20040224963A1 (es) |
| EP (1) | EP1624895A2 (es) |
| JP (1) | JP2006525992A (es) |
| KR (1) | KR20060009314A (es) |
| CN (1) | CN1784243A (es) |
| AU (1) | AU2004237153A1 (es) |
| BR (1) | BRPI0410173A (es) |
| CA (1) | CA2525225A1 (es) |
| CO (1) | CO5700713A2 (es) |
| MX (1) | MXPA05012088A (es) |
| NO (1) | NO20055767L (es) |
| RU (1) | RU2005131497A (es) |
| WO (1) | WO2004098580A2 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE521512C2 (sv) | 2001-06-25 | 2003-11-11 | Niconovum Ab | Anordning för administrering av en substans till främre delen av en individs munhåla |
| EP1575901B1 (en) * | 2002-12-19 | 2012-10-10 | Merck Sharp & Dohme Corp. | Substituted amides |
| EP1578422B1 (en) | 2002-12-20 | 2007-04-11 | NicoNovum AB | A physically and chemically stable nicotine and micorcrystalline cellulose containing particulate material |
| US9402809B2 (en) | 2006-03-16 | 2016-08-02 | Niconovum Usa, Inc. | Snuff composition |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2692575B1 (fr) * | 1992-06-23 | 1995-06-30 | Sanofi Elf | Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant. |
| EP0937077B1 (en) * | 1996-10-30 | 2006-05-17 | Pfizer Inc. | Pyridone-fused azabicyclic- or cytisine derivatives, their preparation and their use in addiction therapy |
| FR2758723B1 (fr) * | 1997-01-28 | 1999-04-23 | Sanofi Sa | Utilisation des antagonistes des recepteurs aux cannabinoides centraux pour la preparation de medicaments |
| DK1044189T4 (en) * | 1997-12-31 | 2015-03-30 | Pfizer Prod Inc | Aryl-fused fused azapolycyclic connections |
| CN1144787C (zh) * | 1998-04-29 | 2004-04-07 | 辉瑞产品公司 | 芳基稠合氮杂多元环化合物 |
| FR2804604B1 (fr) * | 2000-02-09 | 2005-05-27 | Sanofi Synthelabo | Utilisation d'un antagoniste des recepteurs aux cannabinoides centraux pour la preparation de medicaments utiles pour faciliter l'arret de la consommation de tabac |
| TWI231757B (en) * | 2001-09-21 | 2005-05-01 | Solvay Pharm Bv | 1H-Imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity |
-
2004
- 2004-03-04 US US10/793,112 patent/US20040224963A1/en not_active Abandoned
- 2004-05-05 EP EP04731228A patent/EP1624895A2/en not_active Withdrawn
- 2004-05-05 CN CNA2004800126254A patent/CN1784243A/zh active Pending
- 2004-05-05 JP JP2006506619A patent/JP2006525992A/ja active Pending
- 2004-05-05 CA CA002525225A patent/CA2525225A1/en not_active Abandoned
- 2004-05-05 BR BRPI0410173-1A patent/BRPI0410173A/pt not_active IP Right Cessation
- 2004-05-05 KR KR1020057021204A patent/KR20060009314A/ko not_active Application Discontinuation
- 2004-05-05 WO PCT/IB2004/001552 patent/WO2004098580A2/en not_active Application Discontinuation
- 2004-05-05 AU AU2004237153A patent/AU2004237153A1/en not_active Abandoned
- 2004-05-05 MX MXPA05012088A patent/MXPA05012088A/es not_active Application Discontinuation
- 2004-05-05 RU RU2005131497/15A patent/RU2005131497A/ru not_active Application Discontinuation
-
2005
- 2005-11-09 CO CO05113614A patent/CO5700713A2/es not_active Application Discontinuation
- 2005-12-05 NO NO20055767A patent/NO20055767L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004098580A2 (en) | 2004-11-18 |
| MXPA05012088A (es) | 2006-02-22 |
| EP1624895A2 (en) | 2006-02-15 |
| US20040224963A1 (en) | 2004-11-11 |
| AU2004237153A1 (en) | 2004-11-18 |
| JP2006525992A (ja) | 2006-11-16 |
| NO20055767L (no) | 2005-12-05 |
| KR20060009314A (ko) | 2006-01-31 |
| BRPI0410173A (pt) | 2006-05-16 |
| CN1784243A (zh) | 2006-06-07 |
| WO2004098580A3 (en) | 2005-01-06 |
| CA2525225A1 (en) | 2004-11-18 |
| RU2005131497A (ru) | 2006-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GT200100055A (es) | Una composicion farmaceutica para el tratamiento del dolor agudo, cronico y/o el dolor neuropatico y las migrañas. | |
| AR063148A1 (es) | Composicion para tratar la dependencia a la nicotina que comprende al menos un antagonista del receptor nicotinico alfa 3 beta 4 y al menos un metabolito de l a nicotina y su uso para preparar un medicamento | |
| AR033444A1 (es) | Forma solida de dosificacion util para la administracion oral de un compuesto activo de nicotina, a traves de la mucosa y uso de un compuesto activo de nicotina para prepararla | |
| NO993520D0 (no) | Doseringsformer og fremgangsmåte for å bedre erektil dysfunksjon | |
| PE20081297A1 (es) | Forma de dosificacion transdermica resistente a la manipulacion | |
| CO5680428A2 (es) | Antagonistas del receptor de trombina | |
| TR200001942T2 (tr) | Opioid agonist/antagonist kombinasyonlar | |
| PE20060594A1 (es) | Composicion farmaceutica que contiene un agonista de ppar | |
| PE20081649A1 (es) | Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos | |
| DK1530469T3 (da) | Transdermal dosisform omfattende et aktivt middel og et salt og fri baseform af en antagonist | |
| AR048431A1 (es) | Formulaciones galenicas de compuestos organicos | |
| KR970009799A (ko) | 물질 남용 금단의 치료 방법 | |
| EA200100284A1 (ru) | Агонисты 5ht1 рецепторов и метоклопрамид для лечения мигрени | |
| Ackler et al. | Navitoclax (ABT‐263) and bendamustine±rituximab induce enhanced killing of non‐Hodgkin's lymphoma tumours in vivo | |
| EA201071094A1 (ru) | Тризамещенные 1,2,4-триазолы в качестве модуляторов никотиновых ацетилхолиновых рецепторов | |
| BRPI0810525B8 (pt) | uso de pioglitazona ou rosiglitazona pra tratar a dependência em álcool, cocaína e nicotina, composições farmacêuticas e formas de dosagem, e combinações farmacêuticas contendo pioglitazona ou rosiglitazona | |
| BR0314271A (pt) | Forma de dosagem oral sólida útil para administração oral transmucosal, e, métodos de reduzir apetências por nicotina, e, uso de tabaco | |
| SE0002754D0 (sv) | New pharmaceutical combination formulation and method of treatment with the combination | |
| BRPI0413693A (pt) | composição farmacêutica para a prevenção e tratamento da viciação em um mamìfero | |
| CO5700713A2 (es) | Una composicion farmaceutica para la prevencion y tratamiento de adiccion a nicotina en un mamifero | |
| AR063497A1 (es) | Compuesto de pirrodinil -2-ona, intermediario para la sintesis del mismo, composicion farmaceutica que lo comprende y su uso para preparar un medicamento | |
| HUP0003410A2 (hu) | Azapoliciklusos vegyületeket tartalmazó kombinációs gyógyszerkészítmények emlősök nikotinélvezetének megelőzésére és kezelésére | |
| EA200870182A1 (ru) | Применение комбинации морфина и по меньшей мере одного антагониста опиатов для лечения зависимости от опиатов для предотвращения непероральной опиатомании у наркоманов | |
| TW200616955A (en) | Novel tetrahydrocarbazole derivatives having improved biological action and improved solubility as ligands of g-protein coupled receptors (gpcrs) | |
| CO5160295A1 (es) | Nuevas combinaciones farmaceuticas para inhibidores de la nos cionalmente un ssri |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Application refused |